Statutory Profit Doesn't Reflect How Good R&G PharmaStudies' (SZSE:301333) Earnings Are

Even though R&G PharmaStudies Co., Ltd. (SZSE:301333 ) posted strong earnings, investors appeared to be underwhelmed. We have done some analysis and have found some comforting factors beneath the pro

Simply Wall StApr 28 20:40 ET

Northgate (301333.SZ) announced first-quarter results, net profit of 23.489 million yuan, a decrease of 19.95%

Northgate (301333.SZ) released its report for the first quarter of 2024. The company's revenue was 177 million...

Zhitong FinanceApr 21 03:57 ET

Norske (301333.SZ): Harmonious Growth Phase II and Harmonious Health plan to reduce their total holdings by no more than 3%

Gelonghui (301333.SZ) announced that shareholders holding 4,800,000 shares of the company (accounting for 5.0000% of the company's total share capital) Harmonious Growth Phase II (Yiwu) Investment Center (“Harmonious Growth Phase II”) and shareholders holding 2,155,200 shares of the company (accounting for 2.2450% of the company's total share capital ratio), Zhuhai Harmonious Health Investment Fund (limited partnership) (“Harmonious Health”) plan to reduce their share holdings through bulk transactions and centralized bidding transactions. Proposed reduction of shareholding by 2,880,000, proposed reduction of holdings

Gelonghui FinanceMar 28 06:35 ET

R&G PharmaStudies Co., Ltd.'s (SZSE:301333) Market Cap Dropped CN¥422m Last Week; Individual Investors Who Hold 51% Were Hit as Were Institutions

Key Insights R&G PharmaStudies' significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public The top 3 shareholders own 53% of the co

Simply Wall StMar 7 18:31 ET

Northcog (301333.SZ): As of February 20, 2024, the total number of shareholders of the company was 4,750

On February 22, GLONGHUI (301333.SZ) said on the interactive platform that as of February 20, 2024, the total number of shareholders of the company was 4,750.

Gelonghui FinanceFeb 22 02:07 ET

Norske (301333.SZ): Plans to set up an industrial fund to invest in healthcare industries such as biomedical innovation and medical device companies in the early to medium term

Gelonghui, Feb. 19, 丨 Norske (301333.SZ) announced that the company held the 17th meeting of the fourth board of directors on February 19, 2024 to review and pass the “Proposal on Joint Investment with Professional Institutions to Establish Industrial Funds”. The board of directors agreed that the company and CICC Capital jointly invest in the establishment of an industrial fund Zhongjin Nuosghe (Beijing) partnership (limited partnership) (tentative name, final name is subject to registration by the market supervision and administration department, referred to as “this foreign investment”). The target amount of funds pledged for industrial funds is not less than RMB 500 million, and the initial pledge size is RMB 315 million. incorporation

Gelonghui FinanceFeb 19 06:11 ET